Brands
ITC to acquire J&J’s Savlon, Shower To Shower; expand FMCG portfolio
KOLKATA: Kolkata-headquartered cigarettes-to-hotels conglomerate ITC has entered into an agreement with Johnson & Johnson (J&J) to acquire Savlon and Shower To Shower trademarks and other intellectual property (IP) primarily for use in India in order to expand its FMCG portfolio.
Savlon is an antiseptic brand while Shower To Shower is a personal care product brand.
It should be noted that this acquisition, which will be ITC’s first purchase in the personal care segment, is in line with the company’s growing focus on its non-cigarette FMCG business.
“The company has entered into asset purchase agreements with Johnson & Johnson, India & Johnson & Johnson, Singapore on 12 February for purchase of Savlon and Shower To Shower trademarks and other intellectual property, respectively, primarily for use in India,” ITC said in a BSE filing.
These agreements are subject to customary closing conditions and regulatory permissions as may be necessary, the filing further reveals.
A senior official on the condition of anonymity said that the company has used inorganic route to expand and strengthen its business earlier. “We acquired juice brand B Natural for our entry into fruit beverages market,” he said.
When being asked to comment on the revenues ITC is looking at, he said that the current acquisition is in line with ITC’s aim for a revenue of approximately Rs 1,00,000 crore from the new FMCG businesses alone by the end of year 2030.
ITC had acquired Bangalore-based Balan Natural Food’s B Natural brand last year to strengthen its portfolio.
When asked to comment, ITC declined to divulge the size of the deal for purchasing the two brands from Johnson & Johnson.
However when some analysts tracking FMCG firms were contacted to comment on the probabilities of the deal, they assume that the size of the current acquisition would be small compared to ITC’s total size of the business.
After this acquisition, the company’s topline in FMCG segment may go up by a small amount of about one per cent, said a Kolkata based analyst.
ITC’s non-cigarette FMCG revenue stood at around Rs 8,122 crore during the financial year 2013-14.
Brands
Sun Pharma launches ‘Heart ke Liye 8’ heart health drive
New campaign urges daily habits to build a stronger heart
MUMBAI: Sun Pharmaceutical Industries Limited has launched its ‘Heart ke Liye 8 – Making India Heart Strong’ campaign, urging Indians to prioritise heart health through simple, consistent daily actions.
The initiative comes at a crucial time. Cardiovascular disease accounts for nearly one-fifth of global heart-related deaths, with Indians often affected almost a decade earlier than many Western populations. The campaign reinforces a clear message: heart health is not built overnight, but through everyday choices.
Speaking on the launch, Sun Pharma senior vice president, marketing and sales Shailesh Joshi, said the company believes prevention is just as important as treatment. He noted that the campaign aims to spark regular conversations around heart health and encourage people to adopt small habits that can make a lasting difference.
At the centre of the campaign is the ‘Heart-strong Man’, a relatable and optimistic character symbolising a well-cared-for heart. The tone remains positive and practical, encouraging individuals to take charge of their wellbeing without fear. The campaign film has been created in multiple Indian languages to ensure wider accessibility.
The initiative is anchored around eight essential pillars of heart health, including eating better, staying physically active, managing weight, keeping blood pressure, blood sugar and cholesterol in check, avoiding tobacco, going for regular health check-ups, managing stress, and getting quality sleep.
Beyond awareness, the company’s Making India Heart Strong initiative takes an integrated approach to prevention and response. Sun Pharma organises around 10,000 heart screening camps annually, screening over 1.2 lakh people each year.
In addition, it conducts CPR training for more than 1.5 lakh individuals annually to strengthen emergency preparedness, while also investing in evidence generation to improve risk assessment and patient outcomes.
Its patient education efforts further extend to more than 15 million individuals every year through in-clinic print materials and awareness programmes, contributing to a broader, long-term effort to reduce the cardiovascular disease burden in India.
